PA
XENT

Perceptive Advisors’s Intersect ENT, Inc XENT Stock Holding History

Perceptive Advisors’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-70,000
Closed -$2.25M – 123
2019
Q1 		$2.25M Buy
+70,000
New +$2.17M 0.06% 73
2015
Q3 		– Sell
-10,251
Closed -$293K – 194
2015
Q2 		$293K Buy
+10,251
New +$269K 0.02% 141

Other funds holding XENT

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Perceptive Advisors's XENT Position: Q2 2019 in Review

Perceptive Advisors sold out of Intersect ENT, Inc (XENT) in Q2 2019, closing a stake of 70,000 shares — an estimated $2.25M sold.

Perceptive Advisors first reported a position in XENT in Q2 2015 and held it in 2 quarters. The position peaked at $2.25M in Q1 2019. 112 funds tracked by Wall St. Rank hold XENT as of Q2 2019.

  • Perceptive Advisors reported no remaining Intersect ENT, Inc position as of Q2 2019 after selling out during the quarter.
  • Perceptive Advisors sold 70,000 Intersect ENT, Inc shares in Q2 2019, an estimated $2.25M.
  • Perceptive Advisors first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 2 quarters.
  • Perceptive Advisors's Intersect ENT, Inc position peaked at $2.25M in Q1 2019.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2019.

Based on Perceptive Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.